Organon & Co.
| Company type | Public |
|---|---|
| Industry | Pharmaceuticals |
| Predecessor | Organon International |
| Founded |
|
| Headquarters | 30 Hudson Street, , U.S. |
Key people | Kevin Ali (CEO) |
| Revenue | US$6.40 billion (2024) |
| US$1.37 billion (2024) | |
| US$864 million (2024) | |
| Total assets | US$13.1 billion (2024) |
| Total equity | US$472 million (2024) |
Number of employees | c. 10,000 (2024) |
| Website | organon |
| Footnotes / references | |
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States.